TY - JOUR
T1 - Tear Film MicroRNAs as Potential Biomarkers
T2 - A Review
AU - Altman, Jeremy
AU - Jones, Garrett
AU - Ahmed, Saleh
AU - Sharma, Shruti
AU - Sharma, Ashok
N1 - Funding Information:
This research was funded by the National Institutes of Health, National Eye Institute (Bethesda, MD, USA) grant# R01 EY029728 awarded to Ashok Sharma, grant# R01 EY026936 awarded to Shruti Sharma, and grant# P30 EY031631 Center Core Grant for Vision Research.
Publisher Copyright:
© 2023 by the authors.
PY - 2023/2
Y1 - 2023/2
N2 - MicroRNAs are non-coding RNAs that serve as regulatory molecules in a variety of pathways such as inflammation, metabolism, homeostasis, cell machinery, and development. With the progression of sequencing methods and modern bioinformatics tools, novel roles of microRNAs in regulatory mechanisms and pathophysiological states continue to expand. Advances in detection methods have further enabled larger adoption of studies utilizing minimal sample volumes, allowing the analysis of microRNAs in low-volume biofluids, such as the aqueous humor and tear fluid. The reported abundance of extracellular microRNAs in these biofluids has prompted studies to explore their biomarker potential. This review compiles the current literature reporting microRNAs in human tear fluid and their association with ocular diseases including dry eye disease, Sjögren’s syndrome, keratitis, vernal keratoconjunctivitis, glaucoma, diabetic macular edema, and diabetic retinopathy, as well as non-ocular diseases, including Alzheimer’s and breast cancer. We also summarize the known roles of these microRNAs and shed light on the future progression of this field.
AB - MicroRNAs are non-coding RNAs that serve as regulatory molecules in a variety of pathways such as inflammation, metabolism, homeostasis, cell machinery, and development. With the progression of sequencing methods and modern bioinformatics tools, novel roles of microRNAs in regulatory mechanisms and pathophysiological states continue to expand. Advances in detection methods have further enabled larger adoption of studies utilizing minimal sample volumes, allowing the analysis of microRNAs in low-volume biofluids, such as the aqueous humor and tear fluid. The reported abundance of extracellular microRNAs in these biofluids has prompted studies to explore their biomarker potential. This review compiles the current literature reporting microRNAs in human tear fluid and their association with ocular diseases including dry eye disease, Sjögren’s syndrome, keratitis, vernal keratoconjunctivitis, glaucoma, diabetic macular edema, and diabetic retinopathy, as well as non-ocular diseases, including Alzheimer’s and breast cancer. We also summarize the known roles of these microRNAs and shed light on the future progression of this field.
KW - Alzheimer’s and breast cancer
KW - biomarker
KW - microRNA
KW - ocular diseases
KW - tear film
UR - http://www.scopus.com/inward/record.url?scp=85149014069&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85149014069&partnerID=8YFLogxK
U2 - 10.3390/ijms24043694
DO - 10.3390/ijms24043694
M3 - Review article
C2 - 36835108
AN - SCOPUS:85149014069
SN - 1661-6596
VL - 24
JO - International journal of molecular sciences
JF - International journal of molecular sciences
IS - 4
M1 - 3694
ER -